SEC 13F Intelligence

Primecap Management Co/Ca/ / BMY

Primecap Management Co/Ca/’s Bristol-Myers Squibb Co Position

Does Primecap Management Co/Ca/ own Bristol-Myers Squibb Co (BMY)? Yes — 24.99M shares worth $1.5B (+1.19% of its 13F portfolio) as of Q1 2026, up from 24.88M shares the prior filed quarter.

Position Value
$1.5B
Q1 2026
Shares
24.99M
% of Portfolio
+1.19%
Quarters Held
30
currently held

Position History BMY

Reported value by quarter
Q4 ’18: $966MQ4 ’18Q1 ’19: $1.0BQ2 ’19: $987MQ3 ’19: $1.1BQ4 ’19: $1.5BQ4 ’19Q1 ’20: $1.2BQ2 ’20: $1.2BQ3 ’20: $1.2BQ4 ’20: $1.2BQ4 ’20Q1 ’21: $1.2BQ2 ’21: $1.3BQ3 ’21: $1.1BQ4 ’21: $1.4BQ4 ’21Q1 ’22: $1.6BQ2 ’22: $1.7BQ3 ’22: $1.6BQ4 ’22: $1.6BQ4 ’22Q1 ’23: $1.5BQ2 ’23: $1.3BQ3 ’23: $1.2BQ4 ’23: $1.2BQ4 ’23Q1 ’24: $1.3BQ2 ’24: $976MQ3 ’24: $1.2BQ4 ’24: $1.3BQ4 ’24Q1 ’25: $1.4BQ2 ’25: $1.1BQ3 ’25: $996MQ4 ’25: $1.3BQ4 ’25Q1 ’26: $1.5Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202624.99M$1.5B+1.19%
Q4 202524.88M$1.3B+1.02%
Q3 202522.09M$996M+0.76%
Q2 202522.94M$1.1B+0.84%
Q1 202522.97M$1.4B+1.16%
Q4 202422.77M$1.3B+1.00%
Q3 202423.37M$1.2B+0.89%
Q2 202423.50M$976M+0.71%
Q1 202423.27M$1.3B+0.94%
Q4 202323.53M$1.2B+0.96%
Q3 202320.54M$1.2B+1.01%
Q2 202320.95M$1.3B+1.12%
Q1 202321.51M$1.5B+1.30%
Q4 202221.86M$1.6B+1.44%
Q3 202222.14M$1.6B+1.52%
Q2 202222.21M$1.7B+1.53%
Q1 202222.37M$1.6B+1.23%
Q4 202122.11M$1.4B+0.95%
Q3 202118.92M$1.1B+0.79%
Q2 202118.93M$1.3B+0.85%
Q1 202119.24M$1.2B+0.85%
Q4 202019.54M$1.2B+0.90%
Q3 202019.96M$1.2B+0.99%
Q2 202020.62M$1.2B+1.04%
Q1 202021.72M$1.2B+1.19%
Q4 201922.82M$1.5B+1.06%
Q3 201922.40M$1.1B+0.91%
Q2 201921.76M$987M+0.73%
Q1 201921.75M$1.0B+0.76%
Q4 201818.58M$966M+0.78%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Primecap Management Co/Ca/’s full portfolio or all institutional holders of BMY.